The State Food and Drug Administration (SFDA) issued the No.65 Drug Administrative Protection Announcement on July 8, 2005, declaring the ending of drug administrative protection for Merck Co., Inc's Timoptol-Xe (timolol maleate ophthalmic gel forming solution).